中際旭創(300308.SZ):擬出資3000萬元參與投資荷塘半導體基金
格隆匯1月19日丨中際旭創(300308.SZ)公佈,公司於2022年1月19日召開第四屆董事會第二十一次會議和第四屆監事會第十九次會議,分別審議通過了《關於參與投資荷塘半導體基金的議案》,為加強公司在化合物半導體產業領域的投資佈局,公司作為有限合夥人擬以自有資金3000萬元人民幣與普通合夥人蘇州荷塘創業投資有限公司(以下簡稱“蘇州荷塘”)及其他有限合夥人共同出資設立半導體產業基金蘇州荷塘第三代半導體創業投資合夥企業(有限合夥)(以下簡稱“荷塘半導體基金”;暫定名,最終以工商核准的名稱為準)。
荷塘半導體基金經營範圍:項目投資;創業投資;創業投資諮詢業務;為創業企業提供創業管理服務業務;參與創立投資企業與創業投資管理顧問機構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.